Cumulative Effect Assessment of Common Genetic Variants on Prostate Cancer: Preliminary Studies

Single nucleotide polymorphisms (SNPs) are the most common type of genetic variation among people. Genome Wide Association studies (GWASs) have generated multiple genetic variants associated with prostate cancer (PC) risk. Taking into account previously identified genetic susceptibility variants, th...

Full description

Bibliographic Details
Main Authors: Anca Gabriela Pavel, Danae Stambouli, Gabriela Anton, Ismail Gener, Adrian Preda, Catalin Baston, Constantin Gingu
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/10/11/2733
_version_ 1797468970809294848
author Anca Gabriela Pavel
Danae Stambouli
Gabriela Anton
Ismail Gener
Adrian Preda
Catalin Baston
Constantin Gingu
author_facet Anca Gabriela Pavel
Danae Stambouli
Gabriela Anton
Ismail Gener
Adrian Preda
Catalin Baston
Constantin Gingu
author_sort Anca Gabriela Pavel
collection DOAJ
description Single nucleotide polymorphisms (SNPs) are the most common type of genetic variation among people. Genome Wide Association studies (GWASs) have generated multiple genetic variants associated with prostate cancer (PC) risk. Taking into account previously identified genetic susceptibility variants, the purpose of our study was to determine the cumulative association between four common SNPs and the overall PC risk. A total of 78 specimens from both PC and benign prostate hyperplasia (BPH) patients were included in the study. Genotyping of all selected SNPs was performed using the TaqMan assay. The association between each SNP and the PC risk was assessed individually and collectively. Analysis of the association between individual SNPs and PC risk revealed that only the rs4054823 polymorphism was significantly associated with PC, and not with BPH (<i>p</i> < 0.001). Statistical analysis also showed that the heterozygous genotype of the rs2735839 polymorphism is more common within the BPH group than in the PC group (<i>p</i> = 0.042). The cumulative effect of high-risk alleles on PC was analyzed using a logistic regression model. As a result, the carriers of at least one risk allele copy in each particular region had a cumulative odd ratio (OR) of 1.42 times, compared to subjects who did not have any of these factors. In addition, the combination of these four genetic variants increased the overall risk of PC by 52%. Our study provides further evidence of the cumulative effects of genetic risk factors on overall PC risk. These results should encourage future research to explain the interactions between known susceptibility variants and their contribution to the development and progression of PC disease.
first_indexed 2024-03-09T19:14:52Z
format Article
id doaj.art-1c6710856633470cb698374aa0cb3cc6
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-09T19:14:52Z
publishDate 2022-10-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-1c6710856633470cb698374aa0cb3cc62023-11-24T03:49:49ZengMDPI AGBiomedicines2227-90592022-10-011011273310.3390/biomedicines10112733Cumulative Effect Assessment of Common Genetic Variants on Prostate Cancer: Preliminary StudiesAnca Gabriela Pavel0Danae Stambouli1Gabriela Anton2Ismail Gener3Adrian Preda4Catalin Baston5Constantin Gingu6Cytogenomic Medical Laboratory, Molecular Genetics Department, 014453 Bucharest, RomaniaCytogenomic Medical Laboratory, Molecular Genetics Department, 014453 Bucharest, RomaniaThe Romania Academy, “Stefan S. Nicolau” Institute of Virology, 030304 Bucharest, RomaniaDepartment of Nephrology, Urology, Immunology and Immunology of Transplant, Dermatology, Allergology, Faculty of Medicine, “Carol Davila” University of Medicine and Pharmacy, 010751 Bucharest, RomaniaCenter of Urological Surgery, Dialysis and Renal Transplantation, Fundeni Clinical Institute, 022328 Bucharest, RomaniaDepartment of Nephrology, Urology, Immunology and Immunology of Transplant, Dermatology, Allergology, Faculty of Medicine, “Carol Davila” University of Medicine and Pharmacy, 010751 Bucharest, RomaniaDepartment of Nephrology, Urology, Immunology and Immunology of Transplant, Dermatology, Allergology, Faculty of Medicine, “Carol Davila” University of Medicine and Pharmacy, 010751 Bucharest, RomaniaSingle nucleotide polymorphisms (SNPs) are the most common type of genetic variation among people. Genome Wide Association studies (GWASs) have generated multiple genetic variants associated with prostate cancer (PC) risk. Taking into account previously identified genetic susceptibility variants, the purpose of our study was to determine the cumulative association between four common SNPs and the overall PC risk. A total of 78 specimens from both PC and benign prostate hyperplasia (BPH) patients were included in the study. Genotyping of all selected SNPs was performed using the TaqMan assay. The association between each SNP and the PC risk was assessed individually and collectively. Analysis of the association between individual SNPs and PC risk revealed that only the rs4054823 polymorphism was significantly associated with PC, and not with BPH (<i>p</i> < 0.001). Statistical analysis also showed that the heterozygous genotype of the rs2735839 polymorphism is more common within the BPH group than in the PC group (<i>p</i> = 0.042). The cumulative effect of high-risk alleles on PC was analyzed using a logistic regression model. As a result, the carriers of at least one risk allele copy in each particular region had a cumulative odd ratio (OR) of 1.42 times, compared to subjects who did not have any of these factors. In addition, the combination of these four genetic variants increased the overall risk of PC by 52%. Our study provides further evidence of the cumulative effects of genetic risk factors on overall PC risk. These results should encourage future research to explain the interactions between known susceptibility variants and their contribution to the development and progression of PC disease.https://www.mdpi.com/2227-9059/10/11/2733polymorphismprostate cancercumulative effectgenetic riskgenotyping
spellingShingle Anca Gabriela Pavel
Danae Stambouli
Gabriela Anton
Ismail Gener
Adrian Preda
Catalin Baston
Constantin Gingu
Cumulative Effect Assessment of Common Genetic Variants on Prostate Cancer: Preliminary Studies
Biomedicines
polymorphism
prostate cancer
cumulative effect
genetic risk
genotyping
title Cumulative Effect Assessment of Common Genetic Variants on Prostate Cancer: Preliminary Studies
title_full Cumulative Effect Assessment of Common Genetic Variants on Prostate Cancer: Preliminary Studies
title_fullStr Cumulative Effect Assessment of Common Genetic Variants on Prostate Cancer: Preliminary Studies
title_full_unstemmed Cumulative Effect Assessment of Common Genetic Variants on Prostate Cancer: Preliminary Studies
title_short Cumulative Effect Assessment of Common Genetic Variants on Prostate Cancer: Preliminary Studies
title_sort cumulative effect assessment of common genetic variants on prostate cancer preliminary studies
topic polymorphism
prostate cancer
cumulative effect
genetic risk
genotyping
url https://www.mdpi.com/2227-9059/10/11/2733
work_keys_str_mv AT ancagabrielapavel cumulativeeffectassessmentofcommongeneticvariantsonprostatecancerpreliminarystudies
AT danaestambouli cumulativeeffectassessmentofcommongeneticvariantsonprostatecancerpreliminarystudies
AT gabrielaanton cumulativeeffectassessmentofcommongeneticvariantsonprostatecancerpreliminarystudies
AT ismailgener cumulativeeffectassessmentofcommongeneticvariantsonprostatecancerpreliminarystudies
AT adrianpreda cumulativeeffectassessmentofcommongeneticvariantsonprostatecancerpreliminarystudies
AT catalinbaston cumulativeeffectassessmentofcommongeneticvariantsonprostatecancerpreliminarystudies
AT constantingingu cumulativeeffectassessmentofcommongeneticvariantsonprostatecancerpreliminarystudies